Home > Newsletters > Drug Industry Daily > GPhA: House Held No Joint Stakeholder Meeting Before Nixing REMS Provision
Drug Industry Daily
June 15, 2012 | Vol. 11 No. 118
GPhA: House Held No Joint Stakeholder Meeting Before Nixing REMS Provision
Generic-drug makers are raising concerns with their access to House user fee bill negotiations because unlike the Senate, House lawmakers didn’t hold a joint meeting with the FDA, PhRMA and the Generic Pharmaceutical Association (GPhA) on certain cost-saving provisions of its FDA user fee bill.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.